Voya Investment Management LLC Reduces Holdings in Humana Inc. (NYSE:HUM)

Voya Investment Management LLC trimmed its position in Humana Inc. (NYSE:HUM - Free Report) by 30.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 41,969 shares of the insurance provider's stock after selling 18,019 shares during the quarter. Voya Investment Management LLC's holdings in Humana were worth $10,648,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Pinnacle Wealth Management Advisory Group LLC boosted its stake in Humana by 3.6% during the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock worth $272,000 after purchasing an additional 37 shares during the last quarter. Atlas Brown Inc. raised its position in shares of Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock valued at $1,611,000 after buying an additional 38 shares during the last quarter. Mather Group LLC. lifted its stake in shares of Humana by 21.0% in the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock worth $60,000 after buying an additional 41 shares in the last quarter. Capital Advisors Ltd. LLC boosted its position in Humana by 26.1% during the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock worth $53,000 after acquiring an additional 43 shares during the last quarter. Finally, Retirement Planning Co of New England Inc. grew its stake in Humana by 4.7% during the 4th quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock valued at $245,000 after acquiring an additional 43 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on HUM. Mizuho raised their target price on shares of Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Robert W. Baird boosted their price objective on Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Royal Bank of Canada restated an "outperform" rating and issued a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. StockNews.com raised shares of Humana from a "hold" rating to a "buy" rating in a research report on Monday, April 7th. Finally, Barclays upped their price objective on shares of Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a report on Friday, April 11th. Seventeen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $287.76.

Humana Trading Down 2.3 %

HUM traded down $6.13 during mid-day trading on Thursday, hitting $256.11. 1,753,739 shares of the stock were exchanged, compared to its average volume of 1,752,979. The company has a market cap of $30.91 billion, a PE ratio of 25.74, a PEG ratio of 2.05 and a beta of 0.62. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm's fifty day moving average is $266.18 and its two-hundred day moving average is $270.70. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The business's quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $7.23 earnings per share. Equities analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.38%. Humana's dividend payout ratio (DPR) is presently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.